{"data":[{"accessionNo":"0001493152-26-038125","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001176309","issuerName":"ORAMED PHARMACEUTICALS INC.","ticker":"ORMP","cusip":"68403P203","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Aquamarine Financial (Cayman) Ltd","reportingCik":null,"personType":"OO","sharesOwned":2512175,"percentOfClass":6.04,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ormp"},{"accessionNo":"0001373604-26-000047","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001176309","issuerName":"ORAMED PHARMACEUTICALS INC.","ticker":"ORMP","cusip":"68403P203","securityClass":"Common Stock par value $0.012 per share","eventDate":"2026-06-26","reportingPerson":"Leonard Braden Michael","reportingCik":null,"personType":"IN","sharesOwned":1026269,"percentOfClass":2.5,"filedAt":"2026-06-29","canonicalUrl":"https://xoomar.com/markets/stocks/ormp"},{"accessionNo":"0001373604-26-000047","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001176309","issuerName":"ORAMED PHARMACEUTICALS INC.","ticker":"ORMP","cusip":"68403P203","securityClass":"Common Stock par value $0.012 per share","eventDate":"2026-06-26","reportingPerson":"BML Investment Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":866269,"percentOfClass":2.1,"filedAt":"2026-06-29","canonicalUrl":"https://xoomar.com/markets/stocks/ormp"},{"accessionNo":"0001493152-26-023496","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001176309","issuerName":"ORAMED PHARMACEUTICALS INC.","ticker":"ORMP","cusip":"68403P203","securityClass":"Common Stock","eventDate":"2026-01-14","reportingPerson":"Aquamarine Financial (Cayman) Ltd","reportingCik":null,"personType":"OO","sharesOwned":2047652,"percentOfClass":5.06,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ormp"},{"accessionNo":"0001373604-26-000012","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001176309","issuerName":"ORAMED PHARMACEUTICALS INC.","ticker":"ORMP","cusip":null,"securityClass":"Common Stock par value $0.012 per share","eventDate":"2025-12-31","reportingPerson":"Leonard Braden Michael","reportingCik":null,"personType":"IN","sharesOwned":3287531,"percentOfClass":8.3,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/ormp"},{"accessionNo":"0001373604-26-000012","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001176309","issuerName":"ORAMED PHARMACEUTICALS INC.","ticker":"ORMP","cusip":null,"securityClass":"Common Stock par value $0.012 per share","eventDate":"2025-12-31","reportingPerson":"BML Investment Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3167231,"percentOfClass":7.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/ormp"}],"updatedAt":"2026-11-04T03:24:08.984Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/ormp","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}